Inhibition of fetal thymic caspases abrogates the consequences of adenosine deaminase deficiency.
Van De Wiel
C J
CJ
University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Hooker
S W
SW
Laurent
A B
AB
Vaughn
J G
JG
Blackburn
M R
MR
Kellems
R E
RE
Hershfield
M S
MS
Thompson
L F
LF
D000243:Adenosine Deaminase / Q000172:deficiency*; D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology; D061945:Caspase Inhibitors; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D003838:Deoxyadenine Nucleotides / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009924:Organ Culture Techniques; D016693:Receptors, Antigen, T-Cell, alpha-beta; D013601:T-Lymphocytes / Q000166:cytology; D013950:Thymus Gland / Q000196:embryology / Q000201:enzymology*
D000590:Amino Acid Chloromethyl Ketones; D061945:Caspase Inhibitors; D015853:Cysteine Proteinase Inhibitors; D003838:Deoxyadenine Nucleotides; D016693:Receptors, Antigen, T-Cell, alpha-beta; C096713:benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone; D000243:Adenosine Deaminase; C026600:2'-deoxyadenosine triphosphate